VI
HZNP

Vestcor Inc’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Vestcor Inc’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-96,206
Closed -$11.1M – 1360
2023
Q3 		$11.1M Buy
96,206
+37,042
+63% +$3.98M 0.41% 54
2023
Q2 		$6.08M Sell
59,164
-51,000
-46% -$5.38M 0.22% 109
2023
Q1 		$12M Buy
110,164
+49,778
+82% +$5.5M 0.44% 49
2022
Q4 		$6.87M Buy
60,386
+55,243
+1,074% +$4.59M 0.25% 95
2022
Q3 		$318K Buy
5,143
+129
+3% +$9.01K 0.01% 801
2022
Q2 		$400K Buy
5,014
+1,606
+47% +$152K 0.01% 745
2022
Q1 		$359K Sell
3,408
-3,912
-53% -$381K 0.01% 759
2021
Q4 		$789K Sell
7,320
-1,025
-12% -$112K 0.03% 515
2021
Q3 		$914K Sell
8,345
-424
-5% -$44K 0.03% 459
2021
Q2 		$821K Sell
8,769
-8,608
-50% -$792K 0.03% 522
2021
Q1 		$1.6M Sell
17,377
-773
-4% -$65.2K 0.06% 346
2020
Q4 		$1.33M Buy
18,150
+5,844
+47% +$434K 0.06% 366
2020
Q3 		$956K Buy
12,306
+7,108
+137% +$489K 0.04% 382
2020
Q2 		$289K Buy
+5,198
New +$222K 0.02% 525

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Vestcor Inc's HZNP Position: Q4 2023 in Review

Vestcor Inc sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 96,206 shares — an estimated $11.1M sold.

Vestcor Inc first reported a position in HZNP in Q2 2020 and held it in 14 quarters. The position peaked at $12M in Q1 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Vestcor Inc reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Vestcor Inc sold 96,206 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $11.1M.
  • Vestcor Inc first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2020 and held it in 14 quarters.
  • Vestcor Inc's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $12M in Q1 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Vestcor Inc's 13F filing for Q4 2023, filed 14 Feb 2024.